Circulating Tumor DNA: Towards More Individualized Treatment for Patients with Resectable Colorectal Cancer

ConclusionThe detection of ctDNA is a sensitive and dynamic biomarker for disease recurrence in CRC. Many investigations are underway into ctDNA ’s potential role in surveillance and treatment algorithms, and it has the potential to become a critical biomarker to determine individualized strategies for treatment sequencing, choice, and duration of therapies.
Source: Journal of Gastrointestinal Cancer - Category: Cancer & Oncology Source Type: research